CHA News Article

HRSA Withdraws Proposed Rule on 340B Program

The Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs has announced it will withdraw its proposed “mega rule” for the 340B drug pricing program. Instead, HRSA reports that it will issue guidance addressing many areas of the program in early 2015, with an opportunity for public comment on the new proposed guidance. The previous proposed rule was in final stages of review at the Office of Management and Budget.

CHA will inform members through CHA News when the new guidance is announced.